{"id":105148,"date":"2020-04-11T05:03:36","date_gmt":"2020-04-11T12:03:36","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/04\/csl-behring-and-takeda-pharmaceutical-are-leading-a-coalition-to-develop-a-covid-19-hyperimmune-therapy"},"modified":"2020-04-11T05:03:36","modified_gmt":"2020-04-11T12:03:36","slug":"csl-behring-and-takeda-pharmaceutical-are-leading-a-coalition-to-develop-a-covid-19-hyperimmune-therapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/04\/csl-behring-and-takeda-pharmaceutical-are-leading-a-coalition-to-develop-a-covid-19-hyperimmune-therapy","title":{"rendered":"CSL Behring and Takeda Pharmaceutical Are Leading a Coalition to Develop a COVID-19 Hyperimmune Therapy"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/csl-behring-and-takeda-pharmaceutical-are-leading-a-coalition-to-develop-a-covid-19-hyperimmune-therapy2.jpg\"><\/a><\/p>\n<p>Collaboration will always accelerate society faster than competition ever will:<\/p>\n<p><a href=\"https:\/\/www.google.com\/amp\/s\/www.fool.com\/amp\/investing\/2020\/04\/08\/csl-behring-and-takeda-pharmaceutical-lead-a-coali.aspx\">https:\/\/www.google.com\/amp\/s\/www.fool.com\/amp\/investing\/2020\u2026coali.aspx<\/a><\/p>\n<p>\u201cBiotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX: CSL\/USOTC: CSLLY) and Takeda Pharmaceutical Company Limited (TSE:4502\/NYSE: TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one, unbranded anti-SARS-CoV-2 polyclonal hyperimmune immunoglobulin medicine with the potential to treat individuals with serious complications from COVID-19.\u201d<\/p>\n<hr>\n<p>Six companies will work together to develop a plasma-derived antibody product to fight SARS-CoV-2.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Collaboration will always accelerate society faster than competition ever will: https:\/\/www.google.com\/amp\/s\/www.fool.com\/amp\/investing\/2020\u2026coali.aspx \u201cBiotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX: CSL\/USOTC: CSLLY) and Takeda Pharmaceutical Company Limited (TSE:4502\/NYSE: TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one, unbranded [\u2026]<\/p>\n","protected":false},"author":461,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-105148","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/461"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=105148"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105148\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=105148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=105148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=105148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}